No black box warning on record for Tlando

As of the latest FDA labeling reviewed, Tlando (TESTOSTERONE UNDECANOATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Tlando medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Polycythemia : Monitor hematocrit approximately every 3 months during the first year after beginning TLANDO and then every 6 months thereafter during treatment. Discontinue TLANDO if necessary ( 5.1 ). Venous thromboembolism (VTE) : VTE, including deep vein thrombosis (DVT) and pulmonary embolism (PE) have been reported in patients using testosterone products. Discontinu

No black box warning on record for Tlando

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Polycythemia : Monitor hematocrit approximately every 3 months during the first year after beginning TLANDO and then every 6 months thereafter during treatment. Discontinue TLANDO if necessary ( 5.1 ). Venous thromboembolism (VTE) : VTE, including deep vein thrombosis (DVT) and pulmonary embolism (PE) have been reported in patients using testosterone products. Discontinu

Tlando Black Box Warning

No black box warning on record for Tlando

Other warnings & precautions

Tlando Black Box Warning

No black box warning on record for Tlando

Other warnings & precautions